XML 79 R63.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Business Combinations and Acquisitions - Schedule of Recognized Identified Assets Acquired and Liabilities Assumed (Details) - USD ($) $ in Millions |  |  |  |  | 1 Months Ended | 2 Months Ended | 4 Months Ended | 6 Months Ended | 10 Months Ended | 12 Months Ended
--- | --- | --- | --- | --- | --- | --- | --- | --- | --- | ---
Dec. 01, 2021 | Oct. 20, 2021 | Dec. 18, 2020 | Sep. 01, 2020 | Feb. 28, 2021 | Dec. 31, 2021 | Oct. 19, 2021 | Jun. 30, 2021 | Jun. 30, 2021 | Dec. 31, 2023 | Dec. 31, 2022 | Jun. 30, 2021
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Goodwill |  |  |  |  |  | $ 1,662.6 |  |  |  | $ 1,447.6 | $ 1,418.0 |
GAAP purchase consideration, net of cash acquired |  |  |  |  |  | $ 58.6 | $ 0.9 |  |  | $ 31.4 | $ 6.6 | $ 290.1
Customer relationships | Minimum |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Original Average Life in Years |  | 6 years | 10 years | 10 years |  |  |  |  |  | 6 years |  |
Customer relationships | Maximum |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Original Average Life in Years |  | 13 years | 11 years | 11 years |  |  |  |  |  | 13 years |  |
Developed technology | Minimum |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Original Average Life in Years |  | 5 years | 7 years | 7 years |  |  |  |  |  | 5 years |  |
Developed technology | Maximum |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Original Average Life in Years |  | 16 years | 10 years | 10 years |  |  |  |  |  | 16 years |  |
Trade names |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Original Average Life in Years |  | 10 years | 7 years | 7 years |  |  |  |  |  |  |  |
Trade names | Minimum |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Original Average Life in Years |  |  |  |  |  |  |  |  |  | 3 years |  |
Trade names | Maximum |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Original Average Life in Years |  |  |  |  |  |  |  |  |  | 10 years |  |
Distributor relationships | Minimum |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Original Average Life in Years |  | 7 years |  |  |  |  |  |  |  | 7 years |  |
Distributor relationships | Maximum |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Original Average Life in Years |  | 13 years |  |  |  |  |  |  |  | 13 years |  |
Backlog and other | Minimum |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Original Average Life in Years |  | 1 year |  |  |  |  |  |  |  | 1 year |  |
Backlog and other | Maximum |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Original Average Life in Years |  | 4 years |  |  |  |  |  |  |  | 4 years |  |
Noncompete Agreements |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Original Average Life in Years |  | 1 year |  |  |  |  |  |  |  |  |  |
Noncompete Agreements | Minimum |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Original Average Life in Years |  |  | 2 years | 2 years |  |  |  |  |  |  |  |
Noncompete Agreements | Maximum |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Original Average Life in Years |  |  | 3 years | 3 years |  |  |  |  |  |  |  |
Mirion |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Goodwill |  | $ 1,642.9 |  |  |  |  |  |  |  |  |  |
Total amortizable intangible assets |  | 821.0 |  |  |  |  |  |  |  |  |  |
Cash |  | 101.9 |  |  |  |  |  |  |  |  |  |
Accounts receivable |  | 114.3 |  |  |  |  |  |  |  |  |  |
Cost in excess of billings |  | 63.3 |  |  |  |  |  |  |  |  |  |
Inventory |  | 144.6 |  |  |  |  |  |  |  |  |  |
Property, Plant and Equipment |  | 126.4 |  |  |  |  |  |  |  |  |  |
Other current and non-current assets |  | 24.4 |  |  |  |  |  |  |  |  |  |
Right of use assets |  | 43.3 |  |  |  |  |  |  |  |  |  |
Other non-current assets |  | 10.8 |  |  |  |  |  |  |  |  |  |
Current liabilities |  | (148.2) |  |  |  |  |  |  |  |  |  |
Current lease liability |  | (8.8) |  |  |  |  |  |  |  |  |  |
Deferred contract revenue |  | (58.9) |  |  |  |  |  |  |  |  |  |
Notes payable assumed |  | (3.0) |  |  |  |  |  |  |  |  |  |
Other long-term liabilities |  | (241.4) |  |  |  |  |  |  |  |  |  |
Minority interest |  | (0.3) |  |  |  |  |  |  |  |  |  |
Net tangible assets acquired |  | 168.4 |  |  |  |  |  |  |  |  |  |
Total consideration transferred |  | 2,632.3 |  |  |  |  |  |  |  |  |  |
Less: cash acquired |  | (101.9) |  |  |  |  |  |  |  |  |  |
GAAP purchase consideration, net of cash acquired |  | 2,530.4 |  |  |  |  |  |  |  |  |  |
Mirion | Customer relationships |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Total amortizable intangible assets |  | 338.8 |  |  |  |  |  |  |  |  |  |
Mirion | Developed technology |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Total amortizable intangible assets |  | 234.6 |  |  |  |  |  |  |  |  |  |
Mirion | Trade names |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Total amortizable intangible assets |  | 100.5 |  |  |  |  |  |  |  |  |  |
Mirion | Distributor relationships |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Total amortizable intangible assets |  | 61.1 |  |  |  |  |  |  |  |  |  |
Mirion | Backlog and other |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Total amortizable intangible assets |  | 81.5 |  |  |  |  |  |  |  |  |  |
Mirion | Noncompete Agreements |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Total amortizable intangible assets |  | 4.5 |  |  |  |  |  |  |  |  |  |
Mirion | Medical |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Goodwill |  | 680.4 |  |  |  |  |  |  |  |  |  |
Total amortizable intangible assets |  | 330.5 |  |  |  |  |  |  |  |  |  |
Cash |  | 7.8 |  |  |  |  |  |  |  |  |  |
Accounts receivable |  | 44.0 |  |  |  |  |  |  |  |  |  |
Cost in excess of billings |  | 0.0 |  |  |  |  |  |  |  |  |  |
Inventory |  | 25.1 |  |  |  |  |  |  |  |  |  |
Property, Plant and Equipment |  | 52.6 |  |  |  |  |  |  |  |  |  |
Other current and non-current assets |  | 5.8 |  |  |  |  |  |  |  |  |  |
Right of use assets |  | 22.3 |  |  |  |  |  |  |  |  |  |
Other non-current assets |  | 8.0 |  |  |  |  |  |  |  |  |  |
Current liabilities |  | (31.8) |  |  |  |  |  |  |  |  |  |
Current lease liability |  | (4.1) |  |  |  |  |  |  |  |  |  |
Deferred contract revenue |  | (34.7) |  |  |  |  |  |  |  |  |  |
Notes payable assumed |  | (1.8) |  |  |  |  |  |  |  |  |  |
Other long-term liabilities |  | (70.0) |  |  |  |  |  |  |  |  |  |
Minority interest |  | 0.0 |  |  |  |  |  |  |  |  |  |
Net tangible assets acquired |  | 23.2 |  |  |  |  |  |  |  |  |  |
Mirion | Medical | Customer relationships |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Total amortizable intangible assets |  | 152.7 |  |  |  |  |  |  |  |  |  |
Mirion | Medical | Developed technology |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Total amortizable intangible assets |  | 66.3 |  |  |  |  |  |  |  |  |  |
Mirion | Medical | Trade names |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Total amortizable intangible assets |  | 36.8 |  |  |  |  |  |  |  |  |  |
Mirion | Medical | Distributor relationships |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Total amortizable intangible assets |  | 52.5 |  |  |  |  |  |  |  |  |  |
Mirion | Medical | Backlog and other |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Total amortizable intangible assets |  | 17.7 |  |  |  |  |  |  |  |  |  |
Mirion | Medical | Noncompete Agreements |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Total amortizable intangible assets |  | 4.5 |  |  |  |  |  |  |  |  |  |
Mirion | Technologies |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Goodwill |  | 962.5 |  |  |  |  |  |  |  |  |  |
Total amortizable intangible assets |  | 490.5 |  |  |  |  |  |  |  |  |  |
Cash |  | 39.5 |  |  |  |  |  |  |  |  |  |
Accounts receivable |  | 70.3 |  |  |  |  |  |  |  |  |  |
Cost in excess of billings |  | 63.3 |  |  |  |  |  |  |  |  |  |
Inventory |  | 119.5 |  |  |  |  |  |  |  |  |  |
Property, Plant and Equipment |  | 72.7 |  |  |  |  |  |  |  |  |  |
Other current and non-current assets |  | 13.3 |  |  |  |  |  |  |  |  |  |
Right of use assets |  | 20.1 |  |  |  |  |  |  |  |  |  |
Other non-current assets |  | 2.8 |  |  |  |  |  |  |  |  |  |
Current liabilities |  | (82.7) |  |  |  |  |  |  |  |  |  |
Current lease liability |  | (4.4) |  |  |  |  |  |  |  |  |  |
Deferred contract revenue |  | (24.2) |  |  |  |  |  |  |  |  |  |
Notes payable assumed |  | (1.2) |  |  |  |  |  |  |  |  |  |
Other long-term liabilities |  | (147.6) |  |  |  |  |  |  |  |  |  |
Minority interest |  | (0.2) |  |  |  |  |  |  |  |  |  |
Net tangible assets acquired |  | 141.2 |  |  |  |  |  |  |  |  |  |
Mirion | Technologies | Customer relationships |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Total amortizable intangible assets |  | 186.1 |  |  |  |  |  |  |  |  |  |
Mirion | Technologies | Developed technology |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Total amortizable intangible assets |  | 168.3 |  |  |  |  |  |  |  |  |  |
Mirion | Technologies | Trade names |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Total amortizable intangible assets |  | 63.7 |  |  |  |  |  |  |  |  |  |
Mirion | Technologies | Distributor relationships |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Total amortizable intangible assets |  | 8.6 |  |  |  |  |  |  |  |  |  |
Mirion | Technologies | Backlog and other |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Total amortizable intangible assets |  | 63.8 |  |  |  |  |  |  |  |  |  |
Mirion | Technologies | Noncompete Agreements |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Total amortizable intangible assets |  | 0.0 |  |  |  |  |  |  |  |  |  |
Mirion | Corporate |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Goodwill |  | 0.0 |  |  |  |  |  |  |  |  |  |
Total amortizable intangible assets |  | 0.0 |  |  |  |  |  |  |  |  |  |
Cash |  | 54.6 |  |  |  |  |  |  |  |  |  |
Accounts receivable |  | 0.0 |  |  |  |  |  |  |  |  |  |
Cost in excess of billings |  | 0.0 |  |  |  |  |  |  |  |  |  |
Inventory |  | 0.0 |  |  |  |  |  |  |  |  |  |
Property, Plant and Equipment |  | 1.1 |  |  |  |  |  |  |  |  |  |
Other current and non-current assets |  | 5.3 |  |  |  |  |  |  |  |  |  |
Right of use assets |  | 0.9 |  |  |  |  |  |  |  |  |  |
Other non-current assets |  | 0.0 |  |  |  |  |  |  |  |  |  |
Current liabilities |  | (33.7) |  |  |  |  |  |  |  |  |  |
Current lease liability |  | (0.3) |  |  |  |  |  |  |  |  |  |
Deferred contract revenue |  | 0.0 |  |  |  |  |  |  |  |  |  |
Notes payable assumed |  | 0.0 |  |  |  |  |  |  |  |  |  |
Other long-term liabilities |  | (23.8) |  |  |  |  |  |  |  |  |  |
Minority interest |  | (0.1) |  |  |  |  |  |  |  |  |  |
Net tangible assets acquired |  | 4.0 |  |  |  |  |  |  |  |  |  |
Mirion | Corporate | Customer relationships |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Total amortizable intangible assets |  | 0.0 |  |  |  |  |  |  |  |  |  |
Mirion | Corporate | Developed technology |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Total amortizable intangible assets |  | 0.0 |  |  |  |  |  |  |  |  |  |
Mirion | Corporate | Trade names |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Total amortizable intangible assets |  | 0.0 |  |  |  |  |  |  |  |  |  |
Mirion | Corporate | Distributor relationships |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Total amortizable intangible assets |  | 0.0 |  |  |  |  |  |  |  |  |  |
Mirion | Corporate | Backlog and other |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Total amortizable intangible assets |  | 0.0 |  |  |  |  |  |  |  |  |  |
Mirion | Corporate | Noncompete Agreements |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Total amortizable intangible assets |  | $ 0.0 |  |  |  |  |  |  |  |  |  |
CIRS | Customer relationships |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Original Average Life in Years | 7 years |  |  |  |  |  |  |  |  |  |  |
CIRS | Developed technology |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Original Average Life in Years | 5 years |  |  |  |  |  |  |  |  |  |  |
CIRS | Trade names |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Original Average Life in Years | 3 years |  |  |  |  |  |  |  |  |  |  |
CIRS | Backlog and other |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Original Average Life in Years | 2 years |  |  |  |  |  |  |  |  |  |  |
CIRS | Medical |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Goodwill | $ 34.0 |  |  |  |  |  |  |  |  |  |  |
Total amortizable intangible assets | 21.8 |  |  |  |  |  |  |  |  |  |  |
Cash | 1.0 |  |  |  |  |  |  |  |  |  |  |
Accounts receivable | 1.6 |  |  |  |  |  |  |  |  |  |  |
Inventory | 2.0 |  |  |  |  |  |  |  |  |  |  |
Property, Plant and Equipment | 0.4 |  |  |  |  |  |  |  |  |  |  |
Current lease liability | (0.5) |  |  |  |  |  |  |  |  |  |  |
Net tangible assets acquired | (1.7) |  |  |  |  |  |  |  |  |  |  |
Total consideration transferred | 55.1 |  |  |  |  |  |  |  |  |  |  |
Less: cash acquired | (1.0) |  |  |  |  |  |  |  |  |  |  |
GAAP purchase consideration, net of cash acquired | 54.1 |  |  |  |  |  |  |  |  |  |  |
Acquiree revenue post acquisition through the period ended December 31, 2021 | 1.5 |  |  |  |  |  |  |  |  |  |  |
Acquiree income (loss) from operations post acquisition through the period ended December 31, 2021 | (0.1) |  |  |  |  |  |  |  |  |  |  |
CIRS | Medical | Customer relationships |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Total amortizable intangible assets | 1.6 |  |  |  |  |  |  |  |  |  |  |
CIRS | Medical | Developed technology |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Total amortizable intangible assets | 19.2 |  |  |  |  |  |  |  |  |  |  |
CIRS | Medical | Trade names |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Total amortizable intangible assets | 0.4 |  |  |  |  |  |  |  |  |  |  |
CIRS | Medical | Backlog and other |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Total amortizable intangible assets | $ 0.6 |  |  |  |  |  |  |  |  |  |  |
Biodex | Medical |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Goodwill |  |  |  | $ 11.1 |  |  |  |  |  |  |  |
Total amortizable intangible assets |  |  |  | 6.6 |  |  |  |  |  |  |  |
Cash |  |  |  | 4.1 |  |  |  |  |  |  |  |
Accounts receivable |  |  |  | 4.0 |  |  |  |  |  |  |  |
Inventory |  |  |  | 6.4 |  |  |  |  |  |  |  |
Property, Plant and Equipment |  |  |  | 1.0 |  |  |  |  |  |  |  |
Other current and non-current assets |  |  |  | 0.6 |  |  |  |  |  |  |  |
Current liabilities |  |  |  | (2.6) |  |  |  |  |  |  |  |
Deferred contract revenue |  |  |  | (0.2) |  |  |  |  |  |  |  |
Other long-term liabilities |  |  |  | 0.0 |  |  |  |  |  |  |  |
Net tangible assets acquired |  |  |  | 13.3 |  |  |  |  |  |  |  |
Total consideration transferred |  |  |  |  |  |  |  |  | $ 31.0 |  |  |
Less: cash acquired |  |  |  |  |  |  |  |  | (4.1) |  |  |
GAAP purchase consideration, net of cash acquired |  |  |  |  |  |  |  |  | 26.9 |  |  |
Acquiree revenue post acquisition through the period ended December 31, 2021 |  |  |  |  |  |  |  |  | 32.6 |  |  |
Acquiree income (loss) from operations post acquisition through the period ended December 31, 2021 |  |  |  |  |  |  |  |  | $ 0.7 |  |  |
Biodex | Medical | Customer relationships |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Total amortizable intangible assets |  |  |  | 2.3 |  |  |  |  |  |  |  |
Biodex | Medical | Developed technology |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Total amortizable intangible assets |  |  |  | 2.6 |  |  |  |  |  |  |  |
Biodex | Medical | Trade names |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Total amortizable intangible assets |  |  |  | 1.4 |  |  |  |  |  |  |  |
Biodex | Medical | Noncompete Agreements |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Total amortizable intangible assets |  |  |  | $ 0.3 |  |  |  |  |  |  |  |
Sun Nuclear | Medical |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Goodwill |  |  | $ 130.2 |  |  |  |  |  |  |  |  |
Total amortizable intangible assets |  |  | 125.5 |  |  |  |  |  |  |  |  |
Cash |  |  | 18.8 |  |  |  |  |  |  |  |  |
Accounts receivable |  |  | 24.0 |  |  |  |  |  |  |  |  |
Inventory |  |  | 13.9 |  |  |  |  |  |  |  |  |
Property, Plant and Equipment |  |  | 5.9 |  |  |  |  |  |  |  |  |
Other current and non-current assets |  |  | 8.0 |  |  |  |  |  |  |  |  |
Current liabilities |  |  | (9.3) |  |  |  |  |  |  |  |  |
Deferred contract revenue |  |  | (6.5) |  |  |  |  |  |  |  |  |
Other long-term liabilities |  |  | (33.6) |  |  |  |  |  |  |  |  |
Net tangible assets acquired |  |  | 21.2 |  |  |  |  |  |  |  |  |
Total consideration transferred |  |  |  |  |  |  |  | $ 276.9 |  |  |  |
Less: cash acquired |  |  |  |  |  |  |  | (18.8) |  |  |  |
GAAP purchase consideration, net of cash acquired |  |  |  |  |  |  |  | 258.1 |  |  |  |
Acquiree revenue post acquisition through the period ended December 31, 2021 |  |  |  |  |  |  |  | 48.9 |  |  |  |
Acquiree income (loss) from operations post acquisition through the period ended December 31, 2021 |  |  |  |  |  |  |  | $ (5.5) |  |  |  |
Cash consideration paid by GSAH |  |  |  |  | $ 261.9 |  |  |  |  |  |  |
Business combination, deferred consideration |  |  |  |  | $ 15.0 |  |  |  |  |  |  |
Sun Nuclear | Medical | Customer relationships |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Total amortizable intangible assets |  |  | 59.5 |  |  |  |  |  |  |  |  |
Sun Nuclear | Medical | Developed technology |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Total amortizable intangible assets |  |  | 46.5 |  |  |  |  |  |  |  |  |
Sun Nuclear | Medical | Trade names |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Total amortizable intangible assets |  |  | 12.0 |  |  |  |  |  |  |  |  |
Sun Nuclear | Medical | Noncompete Agreements |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Total amortizable intangible assets |  |  | $ 7.5 |  |  |  |  |  |  |  |  |

X
- Definition Business Combination, Deferred Consideration + References No definition available. + Details
Name: | mir_BusinessCombinationDeferredConsideration
Namespace Prefix: | mir_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cost in Excess of Billings + References No definition available. + Details
Name: | mir_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCostInExcessOfBillings
Namespace Prefix: | mir_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Minority Interest + References No definition available. + Details
Name: | mir_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMinorityInterest
Namespace Prefix: | mir_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Notes Payable Assumed + References No definition available. + Details
Name: | mir_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNotesPayableAssumed
Namespace Prefix: | mir_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Other Current And Noncurrent Assets + References No definition available. + Details
Name: | mir_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherCurrentAndNoncurrentAssets
Namespace Prefix: | mir_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Right of Use Assets + References No definition available. + Details
Name: | mir_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets
Namespace Prefix: | mir_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Business Combination Recognized Identifiable Tangible Assets Acquired And Liabilities Assumed Net + References No definition available. + Details
Name: | mir_BusinessCombinationRecognizedIdentifiableTangibleAssetsAcquiredAndLiabilitiesAssumedNet
Namespace Prefix: | mir_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 350 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a)(3) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482665/350-30-50-1 + Details
Name: | us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 805 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5 + Details
Name: | us-gaap_BusinessAcquisitionLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 30 -Paragraph 8 -SubTopic 30 -Topic 805 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479637/805-30-30-8 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b) -SubTopic 30 -Topic 805 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 30 -Paragraph 7 -SubTopic 30 -Topic 805 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479637/805-30-30-7 + Details
Name: | us-gaap_BusinessCombinationConsiderationTransferred1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition This element represents the amount of earnings or loss of the acquiree since the acquisition date included in the consolidated income statement for the reporting period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2 + Details
Name: | us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition This element represents the amount of revenue of the acquiree since the acquisition date included in the consolidated income statement for the reporting period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2 + Details
Name: | us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of lease obligation assumed in business combination. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1 + Details
Name: | us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1 + Details
Name: | us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1 + Details
Name: | us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1 + Details
Name: | us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1 + Details
Name: | us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The amount of identifiable intangible assets recognized as of the acquisition date. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 55 -Paragraph 37 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479303/805-10-55-37 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1 + Details
Name: | us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The amount of inventory recognized as of the acquisition date. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 55 -Paragraph 37 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479303/805-10-55-37 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1 + Details
Name: | us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1 + Details
Name: | us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1 + Details
Name: | us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The amount of property, plant, and equipment recognized as of the acquisition date. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 55 -Paragraph 37 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479303/805-10-55-37 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1 + Details
Name: | us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 12 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12 + Details
Name: | us-gaap_CashAcquiredFromAcquisition
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 852 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 24 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(15)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1 Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1 Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (h) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 942 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03(10)(1)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1 + Details
Name: | us-gaap_Goodwill
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 805 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13 + Details
Name: | us-gaap_PaymentsToAcquireBusinessesGross
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13 + Details
Name: | us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mir_DistributorRelationshipsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mir_BacklogAndOtherMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=mir_MirionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=mir_MedicalSegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=mir_TechnologiesSegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateAndOtherMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=mir_CIRSMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=mir_BiodexMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=mir_SunnuclearMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |